LaVoieHealthScience

Alphabetical Index | Geographical Index | Specialty Index

---

LaVoieHealthScience

One Thompson Square, #503, Boston, MA 02129

617/374-8800

schoe@lavoiehealthscience.com

https://lavoiehealthscience.com
Strategic communications including public relations, investor relations and corporate communications, as well as marketing and digital communications.

Employees: 15. Founded: 2001.

Agency Statement:

(L to R) Sharon Correia, EVP, strategy and integrated communications; Lisa Descenza, VP, integrated communications; Paul Sagan, VP, IR & corp. comms; Donna L. LaVoie, president & CEO; Ella Deych, VP, finance and chief operations officer; Sharon Choe, SVP, investor access and bus dev; Douglas Russell, SVP, client service & PR/media; Harriet Ulmann, AVP, PR & product communications

LaVoieHealthScience is a health science focused, award winning integrated communications agency providing IR and PR bringing 18 years of industry-tested counsel to more than 375 clients. Our specialized expertise in biotechnology and pharmaceuticals, medical technology and devices, and digital and public health uniquely positions us to help clients make their health and science innovations known, understandable, and approachable to target stakeholders through carefully executed strategies and plans.

The agency has received over 50 awards in recognition of the work it has done for emerging and established industry leaders helping our clients from development to launch to commercialization. We help advance health and science innovations by providing specialized thinking to clients throughout the company and product life cycle building innovation and value for human kind. We offer direct connections to media, investors, partners, advocacy groups, and KOLs. We are focused on building trust and long-term relationships based on the quality of the work that we deliver. Many of our client relationships go back over a decade.

Donna L. LaVoie, pres. & CEO; Douglas Russell, sr. VP & gen. mgr.; Sharon Correia, sr. VP, integrated comms.; Sharon Choe, sr. VP, IR & BD; Paul Sagan, asst. VP, IR & corp. comms.; Lisa DeScenza, asst. VP, integrated comms.; Ella Deych, VP, finance & opers.

58 Greenpoint Ave., Brooklyn, NY 11222
Sharon Choe
917/945-2068

Clients Include:

AC Immune SA
Biotechnology Innovation Association
Newron Pharmaceuticals SpA
Nuritas
Venthera
Celavie Biosciences
TriSalus Life Sciences
Ocugen
Omega Therapeutics
Outlook Therapeutics
Protalix Biotherapeutics
SIRION Biotech
TFF Pharmaceuticals
TG Therapeutics
Xontogeny LLC

 Printer Friendly